PromptCrates
Health & ScienceHealth & Science 6 min read

Utah Pilot Lets Nolla Health's AI Write First Acne Prescriptions

Nolla Health launched a Utah pilot on 5 October 2026 that lets its AI issue first-time topical acne prescriptions after a face scan, under staged physician review.

PC

PromptCrates Editorial

Staff Writer

0 0
Utah Pilot Lets Nolla Health's AI Write First Acne Prescriptions

Nolla Health on Monday, 5 October 2026, launched a Utah pilot in which its AI system can issue a first prescription for acne treatment, not just a refill, after a face scan and a short questionnaire in its Nolla Derm app. The service costs $4.99 a month for Utah residents aged 18 and over, and the company says it is the first organization in the US authorized by a state regulator to let AI write an initial prescription.

The pilot runs under an agreement with Utah's Office of Artificial Intelligence Policy and the state Division of Professional Licensing. The state's register of authorized pilots lists the Nolla Health agreement as signed on 22 September 2026 and limits it to first-time prescriptions and refills of topical acne treatments for adults with mild to moderate acne.

How the Nolla Derm AI prescription works

According to Nolla Health's launch post, each patient verifies their identity, goes through informed consent, answers an intake questionnaire and completes a five-angle face scan. In about 10 to 15 minutes the app produces a treatment plan and, where appropriate, an initial prescription, which is shipped to the patient or sent for pharmacy pickup.

Nolla says the tool is not a general-purpose AI. The company says the system selects between pre-approved topical treatment plans using structured clinical inputs and an AI assessment of the scan, and that the prescription flow has no free-text interface. The Verge, citing Bloomberg, reported that the AI can currently prescribe eight different skin treatments.

In its press release, Nolla said that if the AI cannot confidently select a treatment, the patient is directed to a licensed physician. Patients can message a physician in the app at any time, and the company says those messages are answered by a doctor rather than by AI.

Utah's register sets out the guardrails. Severe acne, pregnancy or plans to become pregnant, breastfeeding, a weakened immune system or a past reaction to a listed medication stop the process. Identity and age are checked against a government photo ID, prescriptions go only to Utah addresses, and pharmacists are told the prescription came from AI and given a physician to contact. The agreement does not cover oral medication or isotretinoin.

Physician oversight steps down in stages

Oversight is designed to loosen over time, with state sign-off at each step. Nolla's launch post says two licensed physicians independently review every AI-generated prescription for the first 100 patients before it reaches them. For up to 500 patients in a second stage, the app issues prescriptions directly and a physician reviews every case afterward. In a third stage, physicians review a sample of at least 10% of prescriptions each month, plus every case involving an escalation or a side effect.

Nolla says stage one lasts at least four weeks and stage two at least eight, and that moving on requires meeting safety targets, including 95% agreement with physicians and zero serious adverse events, plus written approval from the state. The state register likewise says each later stage needs the office's written approval. Nolla's press release describes the later reviews differently, as a daily retroactive review in stage two and a weekly sample in stage three.

The company must also report adverse events to the state within 24 hours and file monthly reports that include how often the AI and the reviewing physicians agreed, according to the register. It must carry professional liability insurance, may not sell or transfer patient data, and cannot use its terms of service to limit its liability for harm.

Why Nolla Health says acne comes first

Nolla presents the pilot as a way to widen access. Its press release says about 100,000 Utahns have active acne at any time but only 10% ever see a dermatologist, that the average wait in the state is 61 days and that 11 counties have no dermatologist at all. It also says licensed clinicians agree with Nolla Derm's treatment recommendations in more than 96% of real-world cases, with the remainder reflecting minor adjustments such as the strength of a topical. That figure is the company's own.

"The real test for AI in healthcare isn't how smart it is. It's whether someone other than the company can shut it off," Dr. Zaid Fadul, Nolla's chief medical advisor, said in the release. Zach Boyd, director of Utah's Office of Artificial Intelligence Policy, said in the same release that the pilot improves access to care for Utahns "while maintaining rigorous oversight and safety."

What the Utah pilot means for AI prescribing

The Verge noted that several other healthcare companies are experimenting with AI-generated prescriptions in Utah, which began allowing AI systems to renew certain medications earlier this year. The state register lists refill and renewal pilots for Doctronic, Legion Health and August AI, all limited to medication a licensed provider has already prescribed. None of the other pilots listed on the register covers first-time prescriptions.

The state is explicit about what its agreements do not mean. The register says taking part in the sandbox does not mean Utah has approved or endorsed a product, that a demonstration period lasts no more than 12 months, and that the office can end an agreement at any time. When PromptCrates checked the register on 6 October, it still listed Nolla's demonstration period as not yet started, although Nolla said the system was available from launch day.

Federal regulators are testing their own routes for AI care tools, such as the FDA TEMPO pilot, while consumer AI is moving closer to clinical records through products like ChatGPT for Healthcare's Epic integration and screening tools like Everlywell's Clairity breast risk test. Nolla says its app has been downloaded more than 175,000 times across 44 states, but AI-issued prescriptions are offered only in Utah for now.

health-scienceNolla HealthUtahAI prescribingdermatology

Related articles